CBAY Overview
Upcoming Projects (CBAY)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CBAY)
-
A Third Opinion: Discussing the potential of Gildead's Seladelpar in PBC after their interim analysis from the ASSURE study
Tickers: GILD, CBAY
Executed On: Jun 14, 2024 at 10:00 AM EDT -
A Second Opinion: Discussing the potential of Gildead's Seladelpar in PBC after their interim analysis from the ASSURE study
Tickers: GILD, CBAY
Executed On: Jun 11, 2024 at 03:00 PM EDT -
Discussing the potential of Gildead's Seladelpar in PBC after their interim analysis from the ASSURE study
Tickers: GILD, CBAY
Executed On: Jun 05, 2024 at 10:30 AM EDT -
A Second Opinion: Discussing the potential of CymaBay's Seladelpar, an investigational drug currently in development for the treatment of patients with PBC
Ticker: CBAY
Executed On: Sep 14, 2023 at 02:00 PM EDT -
Discussing the potential of CymaBay's Seladelpar, an investigational drug currently in development for the treatment of patients with PBC
Ticker: CBAY
Executed On: Jul 19, 2023 at 02:00 PM EDT -
A third look: Discussing the potential of seladelpar, a peroxisome proliferator-activated receptor, in development for PBC with reference to the Phase 2 and Phase 3 ENHANCE studies
Ticker: CBAY
Executed On: Feb 17, 2023 at 02:00 PM EST -
A second look: Discussing the potential of seladelpar, a peroxisome proliferator-activated receptor, in development for PBC with reference to the Phase 2 and Phase 3 ENHANCE studies
Ticker: CBAY
Executed On: Jan 31, 2023 at 06:00 PM EST -
Discussing the potential of seladelpar, a peroxisome proliferator-activated receptor, in development for PBC with reference to the Phase 2 and Phase 3 ENHANCE studies
Ticker: CBAY
Executed On: Jan 31, 2023 at 05:00 PM EST
Upcoming & Overdue Catalysts (CBAY)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CBAY)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
